Maruchi Draws Attention for Endocem Which Improves Weaknesses of Existing Nerve Medicine

WONJU--(Korea Newswire)--Medical equipment specialized company Maruchi(CEO Sung-Wook Jang, www.endocem.com) released Endocem which improves the weaknesses of the nerve medicine auxiliary material MTA (Mineral Trioxide Aggregate).

Mostly used for dental nerve treatment, MTA forms a paste-like compound by reacting with water and hardens quite firmly such that it is used as the material hardening within the teeth, and after hardening, it slowly forms chemical bond with dental surface to seal the treated area of the teeth.

Although MTA is a certain replacement material for dental constituent, its low viscosity renders it difficult to manipulate and apply to detailed areas. Also, it takes long to harden, and the high price due to patent protection is also a weakness.

Endocem introduced by Maruchi complemented physical/chemical weaknesses with patented manufacturing method to increase viscosity, resulting in a very short hardening time of within 3 minutes 15 seconds and an improved sealing. Also, convenient manipulation is suitable for minute dental treatment, and due to a simple manufacturing process, the price was lowered with self-owned patent.

Maruchi CEO Sung-Wook Jang said “when there is a wound on the arm or leg, you sterilize first and treat the wounded area. Likewise for dental treatment, you can use Endocem when damaged or rotten to make a healthy recovery.” ( Inquiries: help@endocem.com)

This is a news release distributed by Korea Newswire on behalf of this company.